Request Consultation
Download Videssa Guide

Provista Blog > 4 Advantages of Improving Early Breast Cancer Detection

Provista Blog

4 Advantages of Improving Early Breast Cancer Detection

Posted by Provista Diagnostics on September 26, 2016

While the majority of breast cancers are diagnosed as a result of an abnormal or unclear mammogram, not all breast abnormalities represent cancer. Improving early breast cancer detection, particularly at an early stage offers the following advantages:


1. Improved Outcomes.png

By reducing false negatives, which delay diagnosis and treatment, we can accurately detect early breast cancers with high confidence and improve outcomes for women.
Download our Breast Cancer Detection Guide




2. Reduced Healthcare Costs.png

By reducing false positives, which can expose women to unnecessary testing, accurate breast cancer detection can minimize unnecessary procedures resulting in healthcare savings.



3. Decrease stress and anxiety of uncertainty.png

A blood-based approach to detect breast cancer based on a patient's biochemical changes can increase confidence in clinical decisions decreasing the stress and anxiety that every woman faces when the answer to "do I have cancer?" is "We're not sure. Let's do more testing" or "Let's wait and see."



4. Reduce the burden of vigilance.png

By offering the clarity of a simple result through a blood test, we make it much easier for women to stay vigilant in protecting their health. 


Although breast cancer detection has come a long way over the past few decades, we are still faced with difficult dilemmas concerning early detection. 

The five-year survival rate for breast cancer detected at an early and treatable stage is 99 percent! By combining the traditional approach of routine breast imaging with additional methods of detection, such as a blood test, breast cancer can be detected at even earlier stages.


Provista Diagnostics

Provista Diagnostics

At Provista Diagnostics, our mission is to develop world-class diagnostic tests for indications in breast and gynecologic cancers. As a leading diagnostics company, our aim is to create, produce and market innovative solutions for unmet clinical needs. Our products and services help to diagnose diseases and inform better clinical decisions, thus enhancing women’s health and quality of life. We do this in a responsible and ethical manner with a commitment to excellence in every aspect of our business.